A comprehensive view of Clinical Trials. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

'Tim-3 Antagonists For The Treatment And Diagnosis Of Cancers' in Patent Application Approval Process (USPTO 20240117044)
Published: April 25, 2024 by NewsRx Pharma Business Daily
FDA accepts for priority review GSK’s application for an expanded indication of Jemperli dostarlimab-gxly plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer
Published: April 24, 2024 by GSK Group (GlaxoSmithKline)
US Patent Issued to Regeneron Pharmaceuticals on April 23 for "Antigen binding molecule formats" (New York Inventors)
Published: April 24, 2024 by U.S. Fed News
Sanofi's rilzabrutinib meets primary endpoint in Phase 3 LUNA 3 study for immune thrombocytopenia; potential for clinically beneficial treatment of several immune diseases underscored, with regulatory submissions in the US and EU expected by year-end
Published: April 23, 2024 by Sanofi SA
INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "METHODS FOR REDUCING ALLOANTIBODY LEVELS IN SUBJECTS IN NEED OF SOLID ORGAN TRANSPLANTATION"
Published: April 22, 2024 by U.S. Fed News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count